Dr. Stiles Named 2016 Catalyst by Biocom
Novoron's CEO & President, Dr. Travis Stiles, was recognized by Biocom: Life Science Association of California, in conjunction with the San Diego Venture Group, with a 2016 Catalyst Award.
Innovative Neuroscience Company Shows at RESI Challenge
Novoron Bioscience took home 3rd Prize in the 2016 Redefining Early Stage Investments (RESI) Innovation Challenge.
Multiple Sclerosis Auckland Research Day 2016: Dr Travis Stiles (full presentation)
Dr Travis Stiles (CEO, Novoron Bioscience) presented at the Multiple Sclerosis Auckland Research Day 2016 to discuss remyelination and the drug design process.
Novoron CEO Addresses MS Groups in New Zealand
Dr. Travis Stiles, Novoron's CEO and President, delivered presentations on remyelination and Novoron's novel drug development program in New Zealand last weekend.
Novoron Recognized as Innovative San Diego Biotech
Our City San Diego named Novoron in the magazine’s list of 25 leading life science companies that could positively impact the San Diego economy in the coming years.
Xconomy Recognizes Novoron as San Diego Life Science Startup to Watch in 2016
Interview: Remyelination in MS with Novoron Bioscience
Brett Drummond interviews Dr. Travis Stiles on Remyelination in MS.
